U.S. market Closed. Opens in 1 day 10 hours 26 minutes

ACER | Acer Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-09-302002-09-302001-09-302000-09-301999-09-30
RevenueN/A1.26MN/AN/A432.12K-246.30K2.91M2.56M1.27M1.27MN/AN/AN/AN/AN/A46.45K46.45KN/AN/A3.92K16.05K249.56K816.24K2.90M
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A266.04K687.51K2.54M
Gross ProfitN/A1.26MN/AN/A432.12K-246.30K2.91M2.56M1.27M1.27MN/AN/AN/AN/AN/A46.45K46.45KN/AN/A3.92K16.05K-16.47K128.73K363.10K
Operating Expenses24.61M17.21M22.80M29.90M21.71M13.95M9.86M14.65M16.34M13.19M9.13M5.97M4.97M4.35M11.97M16.74M14.90M12.20M3.76M121.84K160.30K528.35K975.65K730.47K
Selling, General & Admin12.69M10.70M10.95M16.05M9.26M5.22M3.12M4.26M3.83M3.67M2.51M2.41M2.22M2.02M3.34M3.42M5.46M550.18K3.13M120.35K130.29K528.35K975.65K685.81K
Research & Development11.92M6.51M11.85M13.85M12.45M8.73M6.50M10.04M12.12M9.18M6.32M3.34M2.58M2.11M8.39M13.07M7.61M9.89M632.62KN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/A10.63K68.69K2.15K37.91K303.68K219.94K169.30K216.62K237.16K246.15K1.82M1.76MN/AN/AN/AN/AN/AN/A
Operating Income-24.61M-15.95M-22.80M-29.90M-21.71M-13.95M-7.99M-12.09M-15.07M-11.92M-9.13M-5.97M-4.97M-4.35M-11.97M-16.74M-14.90M-12.20M-3.76M-117.92K-144.25K-544.82K-846.91K-367.37K
Other Expenses / Income-1.62M574.40K-82.62K-1.02M433.10K-246.30K-1.28M74.61K15.62K-4.73M202.96K-3.13K-498.99K2.91M115.15K2.68M838.74K-7.21M-860.55K85.39K-17.80K2.47K-120.00203.07K
Before Tax Income-26.24M-15.37M-22.89M-29.42M-21.28M-14.19M-7.98M-12.02M-15.05M-16.66M-8.93M-5.97M-5.47M-1.43M-11.85M-14.67M-14.06M-19.41M-4.62M-32.53K-162.04K-542.34K-847.03K-164.30K
Income Tax Expenses1.62M-645.31K11.81K-537.75K-432.12K246.30K1.04M-4.74K4.13K2.31M-202.96K5.97M5.47M1.43M11.85M14.67M14.06M19.41M4.62M-30.33K54.91K52.93K33.83K-189.12K
Net Income-27.86M-14.73M-22.90M-28.88M-21.28M-14.19M-7.98M-12.02M-15.05M-16.66M-8.93M-5.97M-5.47M-1.43M-11.85M-14.67M-14.06M-19.41M-4.62M-87.59K-199.16K-597.74K-880.75K-178.25K
Interest Expenses101.43KN/AN/AN/A987.00245.06KN/AN/A1.98K2.27M350.30K3.13K500.65K278.13K19.98K16.10K984.007.32M868.93K55.06K54.16K55.40K33.71K13.95K
Basic Shares Outstanding15.77M14.27M11.12M10.09M8.56M3.69M680.67K565.35K379.63K181.92K78.94K76.86K58.24K42.83K35.99K22.84K18.39K53.38K2.15K227.0041.0043.0048.0047.00
Diluted Shares Outstanding15.77M14.27M11.12M10.09M8.56M3.69M680.67K565.35K379.63K181.92K78.94K76.86K58.24K42.83K35.99K22.84K18.39K53.38K2.15K227.0041.0043.0048.0047.00
EBITDA-24.55M-15.88M-22.73M-28.34M-21.25M-13.95M-6.70M-2.57M-14.66M-11.53M-8.83M-5.76M-4.80M-7.32M-11.77M-18.10M-13.23M-4.95M-2.74M-201.83K-113.49K-531.89K-827.39K-551.31K
EBITDA Margin0.00%-1,260.12%0.00%0.00%-4,918.16%5,661.85%-230.50%-100.46%-1,152.81%-910.49%0.00%0.00%0.00%0.00%0.00%-38,961.47%-28,472.35%0.00%0.00%-5,155.33%-707.07%-213.13%-101.37%-19.00%
EBIT-26.14M-15.37M-22.89M-29.42M-21.71M-13.70M-6.94M-12.02M-15.05M-12.08M-8.78M3.13K500.65K278.13K19.98K16.10K984.007.32M868.93K-62.86K-90.08K-489.42K-813.20K-353.42K
EBIT Margin0.00%-1,220.16%0.00%0.00%-5,024.58%5,563.48%-238.96%-470.36%-1,182.97%-954.03%0.00%0.00%0.00%0.00%0.00%34.67%2.12%0.00%0.00%-1,605.72%-561.24%-196.11%-99.63%-12.18%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-09-302002-09-302001-09-302000-09-301999-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙